Discover

COCP
Cocrystal Pharma, Inc.
1.09
1 x 1.09
1 x 1.13
bid
ask
+
0.01
0.93%
01:29 PM
timesize
Ytd11.22%
1y-31.87%
1.07
day range
1.14
0.76
52 week range
2.67
Open1.08Prev Close1.08Low1.07High1.14Mkt Cap15.03M
Vol68.86KAvg Vol83.98KEPS-0.72P/E-1.51Forward P/E-1.22
Beta1.43Short Ratio0.12Inst. Own6.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg0.99200-d Avg1.081yr Est8.00
Income Statement
Operating Expenses2.58M
Research and Development Expense1.37M
Selling, General and Administrative Expense1.21M
Operating Income-2.58M
Net Income-2.30M
Net Income Common Stock-2.30M
Net Income Common Stock (USD)-2.30M
Consolidated Income-2.30M
Earnings per Basic Share-0.17
Earnings per Basic Share (USD)-0.17
Earnings per Diluted Share-0.17
Earning Before Interest & Taxes (EBIT)-2.30M
Earning Before Interest & Taxes (USD)-2.30M
Weighted Average Shares13.79M
Weighted Average Shares Diluted13.79M
Balance Sheet
Cash and Equivalents4.86M
Cash and Equivalents (USD)4.86M
Trade and Non-Trade Receivables70.00K
Current Assets5.94M
Property, Plant & Equipment Net1.39M
Total Assets7.43M
Debt Current343.00K
Total Debt1.42M
Current Liabilities2.23M
Debt Non-Current1.08M
Total Liabilities3.31M
Accumulated Retained Earnings (Deficit)-344.55M
Shareholders Equity4.12M
Shareholders Equity (USD)4.12M
Assets Non-Current1.49M
Total Debt (USD)1.42M
Liabilities Non-Current1.08M
Trade and Non-Trade Payables1.89M
Tax Assets691.00K
Cash Flow
Depreciation, Amortization & Accretion12.00K
Net Cash Flow / Change in Cash & Cash Equivalents-2.34M
Net Cash Flow from Operations-2.34M
Share Based Compensation84.00K